Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anterior Cruciate Ligament | 87 | 2024 | 423 | 15.060 |
Why?
|
Wound Healing | 49 | 2024 | 2813 | 4.740 |
Why?
|
Tissue Scaffolds | 30 | 2019 | 950 | 4.430 |
Why?
|
Knee Injuries | 20 | 2024 | 495 | 4.180 |
Why?
|
Platelet-Rich Plasma | 18 | 2024 | 181 | 3.860 |
Why?
|
Collagen | 35 | 2022 | 2646 | 3.860 |
Why?
|
Knee Joint | 29 | 2023 | 1686 | 3.390 |
Why?
|
Cartilage, Articular | 14 | 2023 | 1104 | 2.740 |
Why?
|
Osteoarthritis | 9 | 2023 | 1070 | 2.630 |
Why?
|
Fibroblasts | 23 | 2013 | 4177 | 2.300 |
Why?
|
Swine | 50 | 2023 | 5994 | 2.290 |
Why?
|
Synovial Membrane | 9 | 2023 | 536 | 2.210 |
Why?
|
Swine, Miniature | 26 | 2023 | 965 | 1.930 |
Why?
|
Blood Platelets | 15 | 2015 | 2476 | 1.830 |
Why?
|
Sterilization | 4 | 2021 | 132 | 1.820 |
Why?
|
Extracellular Matrix | 11 | 2022 | 1739 | 1.530 |
Why?
|
Tissue Engineering | 13 | 2015 | 1891 | 1.370 |
Why?
|
Synovitis | 2 | 2023 | 217 | 1.260 |
Why?
|
Hydrogels | 6 | 2022 | 745 | 1.240 |
Why?
|
Device Approval | 2 | 2022 | 164 | 1.130 |
Why?
|
Collagen Type I | 6 | 2015 | 620 | 1.060 |
Why?
|
Suture Techniques | 5 | 2015 | 777 | 0.990 |
Why?
|
Collagen Type III | 5 | 2013 | 92 | 0.970 |
Why?
|
Platelet Transfusion | 4 | 2012 | 301 | 0.920 |
Why?
|
Tibia | 11 | 2022 | 1075 | 0.890 |
Why?
|
Osteoarthritis, Knee | 6 | 2024 | 1252 | 0.850 |
Why?
|
Weight-Bearing | 8 | 2015 | 533 | 0.840 |
Why?
|
Models, Animal | 13 | 2015 | 2124 | 0.820 |
Why?
|
Animals | 84 | 2023 | 169337 | 0.800 |
Why?
|
Leukocytes, Mononuclear | 3 | 2012 | 1855 | 0.730 |
Why?
|
Nitrogen | 1 | 2021 | 345 | 0.690 |
Why?
|
Cattle | 11 | 2021 | 3826 | 0.680 |
Why?
|
Platelet Activation | 4 | 2011 | 644 | 0.650 |
Why?
|
Sutures | 4 | 2015 | 283 | 0.630 |
Why?
|
Chondrogenesis | 1 | 2020 | 239 | 0.610 |
Why?
|
Orthopedic Procedures | 7 | 2013 | 1280 | 0.610 |
Why?
|
Joint Instability | 7 | 2012 | 802 | 0.600 |
Why?
|
Sus scrofa | 7 | 2015 | 430 | 0.590 |
Why?
|
Thrombin | 3 | 2011 | 600 | 0.580 |
Why?
|
Femur | 7 | 2021 | 1311 | 0.570 |
Why?
|
Stifle | 4 | 2012 | 28 | 0.550 |
Why?
|
Cell Movement | 7 | 2012 | 5215 | 0.530 |
Why?
|
Triamcinolone Acetonide | 1 | 2016 | 105 | 0.500 |
Why?
|
Ethylene Oxide | 1 | 2015 | 28 | 0.500 |
Why?
|
Mesenchymal Stem Cells | 4 | 2014 | 1671 | 0.500 |
Why?
|
Menisci, Tibial | 5 | 2024 | 267 | 0.490 |
Why?
|
Hindlimb | 5 | 2019 | 516 | 0.460 |
Why?
|
Guided Tissue Regeneration | 2 | 2013 | 88 | 0.460 |
Why?
|
Decorin | 1 | 2014 | 38 | 0.460 |
Why?
|
Tenascin | 1 | 2014 | 61 | 0.450 |
Why?
|
Rotator Cuff | 2 | 2015 | 349 | 0.440 |
Why?
|
Regeneration | 5 | 2015 | 1525 | 0.430 |
Why?
|
Injections, Intra-Articular | 4 | 2022 | 288 | 0.420 |
Why?
|
Bone Development | 3 | 2011 | 473 | 0.420 |
Why?
|
Ligaments | 2 | 2014 | 127 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36849 | 0.420 |
Why?
|
Biological Products | 1 | 2022 | 934 | 0.420 |
Why?
|
Polyglactin 910 | 1 | 2012 | 56 | 0.410 |
Why?
|
Platelet-Derived Growth Factor | 4 | 2011 | 617 | 0.410 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 112 | 0.410 |
Why?
|
Fibrillar Collagens | 1 | 2012 | 42 | 0.410 |
Why?
|
Plasma | 1 | 2015 | 585 | 0.400 |
Why?
|
Random Allocation | 6 | 2015 | 2397 | 0.400 |
Why?
|
Transforming Growth Factor beta1 | 5 | 2011 | 637 | 0.390 |
Why?
|
alpha-Galactosidase | 1 | 2011 | 58 | 0.380 |
Why?
|
Proteome | 2 | 2019 | 1881 | 0.370 |
Why?
|
Cells, Cultured | 16 | 2013 | 19022 | 0.360 |
Why?
|
Bone Transplantation | 3 | 2011 | 925 | 0.360 |
Why?
|
Growth Plate | 1 | 2012 | 276 | 0.360 |
Why?
|
Chondrocytes | 4 | 2021 | 800 | 0.350 |
Why?
|
Erythrocytes | 2 | 2011 | 2421 | 0.350 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 178 | 0.340 |
Why?
|
Medial Collateral Ligament, Knee | 2 | 2007 | 24 | 0.340 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2010 | 196 | 0.340 |
Why?
|
Extracellular Matrix Proteins | 2 | 2013 | 835 | 0.330 |
Why?
|
Cell Count | 3 | 2021 | 1833 | 0.330 |
Why?
|
Surface-Active Agents | 1 | 2009 | 152 | 0.320 |
Why?
|
Sheep | 5 | 2015 | 1451 | 0.320 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2010 | 306 | 0.320 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 848 | 0.320 |
Why?
|
Tissue Adhesives | 1 | 2010 | 179 | 0.310 |
Why?
|
Rupture | 6 | 2014 | 444 | 0.310 |
Why?
|
Knee Prosthesis | 1 | 2011 | 395 | 0.310 |
Why?
|
Athletic Injuries | 3 | 2019 | 1245 | 0.300 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 550 | 0.300 |
Why?
|
Gene Expression Profiling | 4 | 2023 | 9510 | 0.290 |
Why?
|
Tendon Injuries | 1 | 2011 | 329 | 0.290 |
Why?
|
Actins | 8 | 2004 | 2059 | 0.290 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 560 | 0.290 |
Why?
|
Transforming Growth Factor beta | 4 | 2004 | 2003 | 0.290 |
Why?
|
Disease Models, Animal | 13 | 2019 | 18362 | 0.280 |
Why?
|
Cell Culture Techniques | 3 | 2010 | 1667 | 0.280 |
Why?
|
Tensile Strength | 3 | 2013 | 335 | 0.280 |
Why?
|
Fibrin | 1 | 2010 | 514 | 0.280 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 664 | 0.280 |
Why?
|
Connective Tissue | 1 | 2009 | 425 | 0.270 |
Why?
|
Glucocorticoids | 1 | 2016 | 2168 | 0.270 |
Why?
|
Postoperative Complications | 5 | 2017 | 15881 | 0.270 |
Why?
|
Gene Expression Regulation | 4 | 2013 | 11918 | 0.270 |
Why?
|
Matrix Metalloproteinase 1 | 3 | 2017 | 146 | 0.250 |
Why?
|
Dogs | 5 | 2011 | 3846 | 0.250 |
Why?
|
Transgenes | 2 | 2010 | 1015 | 0.250 |
Why?
|
Cell Proliferation | 9 | 2012 | 10478 | 0.240 |
Why?
|
Tendons | 2 | 2009 | 559 | 0.240 |
Why?
|
Muscle Strength | 2 | 2020 | 641 | 0.240 |
Why?
|
Orthopedics | 2 | 2024 | 906 | 0.240 |
Why?
|
Biocompatible Materials | 2 | 2011 | 1704 | 0.240 |
Why?
|
Transplantation, Homologous | 3 | 2013 | 4834 | 0.240 |
Why?
|
Blood Proteins | 1 | 2010 | 1186 | 0.240 |
Why?
|
Synovial Fluid | 3 | 2022 | 393 | 0.240 |
Why?
|
Cytokines | 2 | 2011 | 7445 | 0.230 |
Why?
|
Age Factors | 8 | 2012 | 18471 | 0.230 |
Why?
|
Fractures, Cartilage | 1 | 2004 | 22 | 0.230 |
Why?
|
Cryopreservation | 1 | 2009 | 733 | 0.220 |
Why?
|
Polyethylene Glycols | 1 | 2009 | 1195 | 0.220 |
Why?
|
Rats, Inbred Lew | 3 | 2021 | 1165 | 0.220 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2014 | 101 | 0.220 |
Why?
|
Patellar Ligament | 2 | 2015 | 66 | 0.220 |
Why?
|
Female | 50 | 2024 | 397089 | 0.210 |
Why?
|
Linear Models | 6 | 2019 | 5878 | 0.210 |
Why?
|
Hemostatics | 1 | 2006 | 246 | 0.210 |
Why?
|
Macrophages | 2 | 2015 | 5796 | 0.210 |
Why?
|
Goats | 3 | 2011 | 166 | 0.210 |
Why?
|
Casts, Surgical | 1 | 2024 | 184 | 0.210 |
Why?
|
Transduction, Genetic | 2 | 2010 | 902 | 0.210 |
Why?
|
Temperature | 1 | 2009 | 2235 | 0.200 |
Why?
|
RNA, Messenger | 4 | 2014 | 12805 | 0.200 |
Why?
|
Male | 45 | 2024 | 364902 | 0.200 |
Why?
|
Humans | 64 | 2024 | 768393 | 0.190 |
Why?
|
Powders | 1 | 2021 | 79 | 0.190 |
Why?
|
Sports Medicine | 1 | 2024 | 239 | 0.190 |
Why?
|
Guinea Pigs | 1 | 2022 | 1309 | 0.180 |
Why?
|
Glycosaminoglycans | 2 | 2001 | 611 | 0.180 |
Why?
|
Aging | 5 | 2011 | 8764 | 0.180 |
Why?
|
Materials Testing | 3 | 2012 | 872 | 0.180 |
Why?
|
Adipose Tissue | 1 | 2012 | 3334 | 0.170 |
Why?
|
Gamma Rays | 1 | 2021 | 319 | 0.170 |
Why?
|
Transplantation, Autologous | 3 | 2021 | 2127 | 0.170 |
Why?
|
Rats | 6 | 2021 | 23835 | 0.170 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2007 | 1943 | 0.170 |
Why?
|
Technology | 1 | 2022 | 296 | 0.170 |
Why?
|
Equipment and Supplies | 1 | 2022 | 273 | 0.170 |
Why?
|
Adolescent | 17 | 2024 | 89184 | 0.160 |
Why?
|
Models, Biological | 3 | 2017 | 9493 | 0.160 |
Why?
|
Gene Expression | 5 | 2012 | 7598 | 0.160 |
Why?
|
Coculture Techniques | 2 | 2012 | 1342 | 0.150 |
Why?
|
Radius Fractures | 1 | 2024 | 514 | 0.150 |
Why?
|
Treatment Outcome | 10 | 2020 | 65379 | 0.150 |
Why?
|
Rheology | 2 | 2009 | 348 | 0.150 |
Why?
|
Cell Survival | 4 | 2021 | 5792 | 0.150 |
Why?
|
Analysis of Variance | 5 | 2013 | 6241 | 0.150 |
Why?
|
Gels | 2 | 2010 | 421 | 0.150 |
Why?
|
Time Factors | 8 | 2016 | 40272 | 0.150 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 601 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 157 | 0.140 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2022 | 465 | 0.140 |
Why?
|
Collagen Type II | 2 | 2017 | 151 | 0.140 |
Why?
|
Cell Division | 3 | 2011 | 4479 | 0.140 |
Why?
|
Species Specificity | 2 | 2011 | 2417 | 0.130 |
Why?
|
DNA Fragmentation | 2 | 2006 | 240 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2010 | 11120 | 0.120 |
Why?
|
Radiography | 4 | 2019 | 6993 | 0.120 |
Why?
|
Culture Media | 2 | 2010 | 898 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 998 | 0.120 |
Why?
|
Talus | 2 | 2006 | 88 | 0.120 |
Why?
|
Elastic Modulus | 1 | 2015 | 211 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 2 | 2006 | 612 | 0.110 |
Why?
|
Adenoviridae | 3 | 2010 | 1096 | 0.110 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2013 | 19 | 0.110 |
Why?
|
Blood | 2 | 2015 | 597 | 0.110 |
Why?
|
Electrons | 1 | 2015 | 264 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 9063 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1672 | 0.110 |
Why?
|
Aggrecans | 1 | 2013 | 89 | 0.110 |
Why?
|
Posterior Cruciate Ligament | 1 | 2014 | 86 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4588 | 0.110 |
Why?
|
Fracture Fixation | 2 | 2024 | 371 | 0.110 |
Why?
|
Radiation Dosage | 1 | 2021 | 1974 | 0.100 |
Why?
|
Recovery of Function | 2 | 2015 | 2990 | 0.100 |
Why?
|
Young Adult | 9 | 2024 | 60049 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1999 | 1493 | 0.100 |
Why?
|
Joints | 1 | 2014 | 324 | 0.100 |
Why?
|
DNA | 3 | 2011 | 7211 | 0.100 |
Why?
|
ADAM Proteins | 1 | 2013 | 238 | 0.100 |
Why?
|
Elasticity | 3 | 2009 | 657 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 947 | 0.100 |
Why?
|
Athletes | 1 | 2019 | 1162 | 0.090 |
Why?
|
Cold Temperature | 1 | 2015 | 786 | 0.090 |
Why?
|
Apoptosis | 3 | 2013 | 9516 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2024 | 3486 | 0.090 |
Why?
|
Regenerative Medicine | 1 | 2015 | 311 | 0.090 |
Why?
|
Leg Length Inequality | 1 | 2011 | 56 | 0.090 |
Why?
|
Metabolism | 1 | 2012 | 193 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2663 | 0.090 |
Why?
|
Culture Media, Conditioned | 1 | 2012 | 521 | 0.090 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2010 | 8 | 0.090 |
Why?
|
Diffusion Chambers, Culture | 1 | 2010 | 49 | 0.090 |
Why?
|
Procollagen | 1 | 2011 | 189 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1658 | 0.090 |
Why?
|
Absorbable Implants | 1 | 2012 | 339 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2012 | 11668 | 0.090 |
Why?
|
Epiphyses | 1 | 2011 | 191 | 0.090 |
Why?
|
Equipment Failure | 1 | 2012 | 585 | 0.090 |
Why?
|
Adult | 19 | 2024 | 223640 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1705 | 0.090 |
Why?
|
Suture Anchors | 1 | 2010 | 81 | 0.080 |
Why?
|
Hemorheology | 1 | 2010 | 144 | 0.080 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2009 | 124 | 0.080 |
Why?
|
Growth Differentiation Factors | 1 | 2010 | 100 | 0.080 |
Why?
|
Prospective Studies | 7 | 2023 | 54920 | 0.080 |
Why?
|
Protein Denaturation | 1 | 2009 | 242 | 0.080 |
Why?
|
Periosteum | 1 | 2009 | 139 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1169 | 0.080 |
Why?
|
Cell Shape | 1 | 2010 | 371 | 0.080 |
Why?
|
Awards and Prizes | 1 | 2013 | 365 | 0.080 |
Why?
|
Ligaments, Articular | 1 | 2011 | 308 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3520 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3413 | 0.080 |
Why?
|
Platelet Count | 1 | 2011 | 784 | 0.080 |
Why?
|
Reoperation | 3 | 2023 | 4341 | 0.070 |
Why?
|
Capillaries | 1 | 2011 | 756 | 0.070 |
Why?
|
Single-Blind Method | 1 | 2012 | 1585 | 0.070 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 921 | 0.070 |
Why?
|
Range of Motion, Articular | 2 | 2011 | 1599 | 0.070 |
Why?
|
Rabbits | 2 | 2011 | 4781 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1731 | 0.070 |
Why?
|
Muscle, Smooth | 2 | 2001 | 930 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3107 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5512 | 0.070 |
Why?
|
Injections | 1 | 2009 | 840 | 0.070 |
Why?
|
Body Temperature | 1 | 2009 | 781 | 0.060 |
Why?
|
Femoral Fractures | 1 | 2009 | 376 | 0.060 |
Why?
|
Bone Nails | 1 | 2007 | 220 | 0.060 |
Why?
|
Transplants | 1 | 2008 | 208 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3596 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2009 | 1905 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 848 | 0.060 |
Why?
|
Epitopes | 1 | 2011 | 2525 | 0.060 |
Why?
|
Child | 8 | 2024 | 80891 | 0.060 |
Why?
|
Sports | 1 | 2011 | 703 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4142 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2611 | 0.060 |
Why?
|
Bone Cysts | 1 | 2004 | 48 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1176 | 0.060 |
Why?
|
Arthroscopy | 1 | 2011 | 971 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2010 | 2363 | 0.060 |
Why?
|
Humeral Fractures | 1 | 2007 | 283 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39407 | 0.060 |
Why?
|
Gait | 2 | 2022 | 822 | 0.060 |
Why?
|
X-Ray Microtomography | 2 | 2016 | 457 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3471 | 0.050 |
Why?
|
Risk Factors | 4 | 2022 | 74962 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 1674 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20224 | 0.050 |
Why?
|
United States | 3 | 2023 | 73150 | 0.050 |
Why?
|
Amino Acids | 1 | 2009 | 1716 | 0.050 |
Why?
|
Monocytes | 1 | 2012 | 2595 | 0.050 |
Why?
|
Foreign Bodies | 1 | 2006 | 403 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3230 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5900 | 0.050 |
Why?
|
Cell Line | 1 | 2015 | 15597 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10654 | 0.050 |
Why?
|
Biodegradation, Environmental | 1 | 2001 | 220 | 0.050 |
Why?
|
Chondroitin ABC Lyase | 1 | 2000 | 15 | 0.050 |
Why?
|
Lead | 1 | 2006 | 880 | 0.050 |
Why?
|
Cicatrix | 1 | 2007 | 799 | 0.040 |
Why?
|
Wounds, Gunshot | 1 | 2006 | 588 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2024 | 487 | 0.040 |
Why?
|
Ozone | 1 | 2024 | 490 | 0.040 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2000 | 138 | 0.040 |
Why?
|
Normal Distribution | 1 | 2020 | 272 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2011 | 2906 | 0.040 |
Why?
|
Collagenases | 1 | 2000 | 221 | 0.040 |
Why?
|
Culture Techniques | 1 | 2000 | 530 | 0.040 |
Why?
|
Trypsin | 1 | 2000 | 491 | 0.040 |
Why?
|
Acetaminophen | 1 | 2024 | 556 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3559 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 628 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3707 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2069 | 0.040 |
Why?
|
Middle Aged | 12 | 2019 | 223491 | 0.040 |
Why?
|
Stress, Mechanical | 3 | 2013 | 1680 | 0.040 |
Why?
|
Cartilage | 1 | 2022 | 811 | 0.040 |
Why?
|
Cell Death | 1 | 2004 | 1682 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 41795 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12092 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2022 | 22296 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2024 | 941 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10776 | 0.030 |
Why?
|
Aged | 8 | 2010 | 171562 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2886 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8051 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26375 | 0.030 |
Why?
|
Incidence | 1 | 2013 | 21544 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1890 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2006 | 2062 | 0.030 |
Why?
|
Leadership | 1 | 2023 | 1395 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1830 | 0.030 |
Why?
|
Protein Isoforms | 1 | 1999 | 1703 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 2276 | 0.030 |
Why?
|
Bone Demineralization Technique | 1 | 2013 | 27 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2693 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2014 | 368 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2000 | 1371 | 0.030 |
Why?
|
Choice Behavior | 1 | 2019 | 848 | 0.030 |
Why?
|
Blood Vessels | 1 | 1999 | 1110 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 81801 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2353 | 0.030 |
Why?
|
Logistic Models | 1 | 2006 | 13323 | 0.020 |
Why?
|
Osteonecrosis | 1 | 2013 | 230 | 0.020 |
Why?
|
Teriparatide | 1 | 2013 | 226 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 997 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3906 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2020 | 2660 | 0.020 |
Why?
|
Pediatrics | 1 | 2024 | 3624 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2001 | 2514 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2004 | 59686 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 1804 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15872 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1967 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 797 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3267 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14737 | 0.020 |
Why?
|
Chelating Agents | 1 | 2006 | 385 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42650 | 0.010 |
Why?
|
Foot Injuries | 1 | 2006 | 154 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2011 | 3102 | 0.010 |
Why?
|
Spinal Fusion | 1 | 2013 | 1309 | 0.010 |
Why?
|
Blotting, Western | 2 | 2001 | 5037 | 0.010 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2003 | 71 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2013 | 3579 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6085 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3413 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36510 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6277 | 0.010 |
Why?
|
Ankle Injuries | 1 | 2004 | 338 | 0.010 |
Why?
|
Proteins | 1 | 2014 | 6006 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4076 | 0.010 |
Why?
|
Bone and Bones | 1 | 2008 | 2589 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13503 | 0.010 |
Why?
|
Arthroplasty, Replacement | 1 | 2000 | 310 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3411 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2000 | 1339 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14154 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6510 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2004 | 20765 | 0.000 |
Why?
|